The global cell-based assays market was valued at USD 8,677.43 million in 2023, driven by the rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases worldwide. This market is projected to grow at an impressive compound annual growth rate (CAGR) of 14% during the forecast period from 2024 to 2032, reaching an […]